<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01569282</url>
  </required_header>
  <id_info>
    <org_study_id>Double bypass vs Stent</org_study_id>
    <nct_id>NCT01569282</nct_id>
  </id_info>
  <brief_title>Double Bypass Versus Stent-treatment in Irresectable Pancreatic Cancer</brief_title>
  <official_title>Double Bypass vs Stent Strategy in Peroperatively Diagnosed Irresectable Pancreatic Cancer - A Prospective Randomized Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Göteborg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Göteborg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Double bypass (hepaticojejunostomy + gastrojejunostomy) is compared to stent strategy in
      patients planned for curative pancreatic resection in whom peroperative findings makes
      resection impossible.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Difficulties to recruit patients
  </why_stopped>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Morbidity</measure>
    <time_frame>Day 1-30 after randomization</time_frame>
    <description>Initial morbidity in association to the laparotomy using the Clavien-Dindo Classification.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Preop, 1 month postop and every third month</time_frame>
    <description>Using the EORTC:s QLQ-C30 and QLQ-PAN26 questionaries</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numbers of readmissions to hospital</measure>
    <time_frame>Up to two years after the laparotomy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The numbers of Surgical, Radiological or Endoscopical therapeutic re-interventions</measure>
    <time_frame>Up to 24 months after the randomization</time_frame>
    <description>The numbers of surgical, radiological or endoscopical interventions due to jaundice or gastric outlet obstruction from date of randomization until the date of death from any cause, whichever came first, assessed up to 24 months&quot;</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Pancreatic Cancer</condition>
  <condition>Periampullary Tumor</condition>
  <arm_group>
    <arm_group_label>Double bypass</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Stent Strategy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hepaticojejunostomy and gastroenterostomy</intervention_name>
    <description>Standard surgical techniques</description>
    <arm_group_label>Double bypass</arm_group_label>
    <other_name>Biliodigestive anastomosis</other_name>
    <other_name>Gastrojenunal anastomosis</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stent strategy</intervention_name>
    <description>Biliary and/or enteral stents on demand</description>
    <arm_group_label>Stent Strategy</arm_group_label>
    <other_name>Bile duct stent</other_name>
    <other_name>Gastroduodenal stent</other_name>
    <other_name>Enteral stent</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Preoperatively

               -  Patients with stent treated tumor in the pancreatic head or periampullary planned
                  for pancreaticoduodenectomy

               -  The patient jaundice should have worn off and there should be no signs of
                  duodenal obstruction

               -  The patient has given informed consent after verbal and written information in
                  accordance with approved ethics application

               -  The patient has no anatomical conditions making endoscopic therapy impossible
                  such as previous Billroth II or Gastric Bypass.

          2. Intraoperatively

               -  Peroperative findings of of carcinomatosis, metastases or local irresectability
                  who oppose radical surgery

               -  Surgical double bypass should be technically feasible

               -  The patient has given informed consent after verbal and written information in
                  accordance with approved ethics application

        Exclusion Criteria:

          -  Peroperative signs of dysfunction on biliary stent

          -  Peroperative findings of gastric outlet obstruction

          -  Surgical double bypass not technically feasible
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars Fändriks, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Göteborg University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claes Jönsson, Ass. Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gothenburg Universitity</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Surgery, Sahlgrenska University Hospital</name>
      <address>
        <city>Gothenburg</city>
        <zip>413 45</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of surgery, University Hospital</name>
      <address>
        <city>Linköping</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Surgery, Skane University Hospital</name>
      <address>
        <city>Lund</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gastro Center Surgery, Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Surgery, University Hospital</name>
      <address>
        <city>Umeå</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Surgery, University Hospital</name>
      <address>
        <city>Örebro</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 16, 2012</study_first_submitted>
  <study_first_submitted_qc>March 30, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 3, 2012</study_first_posted>
  <last_update_submitted>April 20, 2015</last_update_submitted>
  <last_update_submitted_qc>April 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Surgical bypass</keyword>
  <keyword>Hepaticojejunostomy</keyword>
  <keyword>Gastrojejunostomy</keyword>
  <keyword>Biliary stent</keyword>
  <keyword>Enteral stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

